BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: He Z, Liu Z, Liu M, Guo C, Xu R, Li F, Liu A, Yang H, Shen L, Wu Q, Duan L, Li X, Zhang C, Pan Y, Cai H, Ke Y. Efficacy of endoscopic screening for esophageal cancer in China (ESECC): design and preliminary results of a population-based randomised controlled trial. Gut 2019;68:198-206. [PMID: 29306867 DOI: 10.1136/gutjnl-2017-315520] [Cited by in Crossref: 49] [Cited by in F6Publishing: 47] [Article Influence: 16.3] [Reference Citation Analysis]
Number Citing Articles
1 Ko JMY, Lam SY, Ning L, Chai AWY, Lei LC, Choi SSA, Wong CWY, Lung ML. RAD50 Loss of Function Variants in the Zinc Hook Domain Associated with Higher Risk of Familial Esophageal Squamous Cell Carcinoma. Cancers (Basel) 2021;13:4715. [PMID: 34572942 DOI: 10.3390/cancers13184715] [Reference Citation Analysis]
2 Ho ALK, Smyth EC. A global perspective on oesophageal cancer: two diseases in one. Lancet Gastroenterol Hepatol 2020;5:521-2. [PMID: 32246940 DOI: 10.1016/S2468-1253(20)30047-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
3 Feng Y, Liang Y, Yao B, Xu J, Zang J, Zhang Y, Zhang J, Xu G, Wei B, Yao X, Huang P, Shi R. A Rapid Cytological Screening as pre-Endoscopy Screening for Early Esophageal Squamous Cell Lesions: A Prospective Pilot Study from a Chinese Academic Center. Technol Cancer Res Treat 2022;21:15330338211066200. [PMID: 35040718 DOI: 10.1177/15330338211066200] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Wang M, Liu M, Li F, Guo C, Liu Z, Pan Y, Liu Y, Liu F, Cai H, Wu Y, He Z, Ke Y. Gender heterogeneity in dyslipidemia prevalence, trends with age and associated factors in middle age rural Chinese. Lipids Health Dis 2020;19:135. [PMID: 32532299 DOI: 10.1186/s12944-020-01313-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
5 Wen X, Wen D, Yang Y, Chen Y, Akazawa K, Liu Y, Shan B. Urban-rural disparity in cervical cancer in China and feasible interventions for tackling the rural excess. Medicine (Baltimore) 2019;98:e13907. [PMID: 30608415 DOI: 10.1097/MD.0000000000013907] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
6 Wang M, Liu M, Guo C, Li F, Liu Z, Pan Y, Liu F, Liu Y, Bao H, Hu Z, Cai H, He Z, Ke Y. Association of early-life undernutrition and risk of dyslipidemia in adulthood: a population-based cohort study. BMC Public Health 2021;21:2129. [PMID: 34801023 DOI: 10.1186/s12889-021-12211-8] [Reference Citation Analysis]
7 He Z, Ke Y. Response. Gastrointest Endosc 2020;92:1137-8. [PMID: 33160494 DOI: 10.1016/j.gie.2020.06.071] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
8 Shi C, Liu M, Liu Z, Guo C, Li F, Xu R, Liu F, Liu Y, Li J, Cai H, He Z, Ke Y. Using health insurance reimbursement data to identify incident cancer cases. Journal of Clinical Epidemiology 2019;114:141-9. [DOI: 10.1016/j.jclinepi.2019.06.009] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
9 Zeng H, Sun K, Cao M, Zheng R, Sun X, Liu S, Zhang Z, Liu Y, Guo G, Song G, Zhu Y, Wu X, Song B, Liao X, Chen Y, Song M, Giovannucci E, Zhuang G, Wei W, Chen W, He J. Initial results from a multi-center population-based cluster randomized trial of esophageal and gastric cancer screening in China. BMC Gastroenterol 2020;20:398. [PMID: 33228549 DOI: 10.1186/s12876-020-01517-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
10 Li J, Xu J, Zheng Y, Gao Y, He S, Li H, Zou K, Li N, Tian J, Chen W, He J. Esophageal cancer: Epidemiology, risk factors and screening. Chin J Cancer Res 2021;33:535-47. [PMID: 34815628 DOI: 10.21147/j.issn.1000-9604.2021.05.01] [Reference Citation Analysis]
11 Zhang Y, Li J, Wang L, Meng P, Zhao J, Han P, Xia J, Xu J, Wang L, Shen F, Zheng A, Zhou F, Fan R. Clinical significance of detecting circulating tumor cells in patients with esophageal squamous cell carcinoma by EpCAM‑independent enrichment and immunostaining‑fluorescence in situ hybridization. Mol Med Rep 2019;20:1551-60. [PMID: 31257510 DOI: 10.3892/mmr.2019.10420] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
12 Li H, Ding C, Zeng H, Zheng R, Cao M, Ren J, Shi J, Sun D, He S, Yang Z, Yu Y, Zhang Z, Sun X, Guo G, Song G, Wei W, Chen W, He J. Improved esophageal squamous cell carcinoma screening effectiveness by risk-stratified endoscopic screening: evidence from high-risk areas in China. Cancer Commun (Lond) 2021;41:715-25. [PMID: 34146456 DOI: 10.1002/cac2.12186] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
13 Wang MM, Guo CH, Li FL, Xu RP, Liu Z, Pan YQ, Liu FF, Liu Y, Cai H, Liu MF, He ZH, Ke Y. Family history of esophageal cancer modifies the association of serum lipids and malignant esophageal lesions: a nested case-control study from the "Endoscopic Screening for Esophageal Cancer in China" trial. Chin Med J (Engl) 2021;134:1079-86. [PMID: 33840743 DOI: 10.1097/CM9.0000000000001432] [Reference Citation Analysis]
14 Cotton CC, Choksi YA. Lack of Iodine Staining Lugol's Chromoendoscopy Predicts Squamous Neoplastic Progression in a High-risk Region of China: Implications for East and West. Clin Gastroenterol Hepatol 2020;18:1439-41. [PMID: 31712079 DOI: 10.1016/j.cgh.2019.11.008] [Reference Citation Analysis]
15 Liu Z, Guo C, He Y, Chen Y, Ji P, Fang Z, Li F, Tang Y, Chen X, Xiao P, Wang C, Yin W, Guo H, Liu M, Pan Y, Liu F, Liu Y, He Z, Ke Y. A clinical model predicting the risk of esophageal high-grade lesions in opportunistic screening: a multicenter real-world study in China. Gastrointest Endosc 2020;91:1253-1260.e3. [PMID: 31911077 DOI: 10.1016/j.gie.2019.12.038] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
16 Wang M, Liu F, Pan Y, Xu R, Li F, Liu A, Yang H, Duan L, Shen L, Wu Q, Liu Y, Liu M, Liu Z, Hu Z, Chen H, Cai H, He Z, Ke Y. Tumor-associated autoantibodies in ESCC screening: Detecting prevalent early-stage malignancy or predicting future cancer risk? EBioMedicine 2021;73:103674. [PMID: 34753106 DOI: 10.1016/j.ebiom.2021.103674] [Reference Citation Analysis]
17 Chen R, Liu Y, Song G, Li B, Zhao D, Hua Z, Wang X, Li J, Hao C, Zhang L, Liu S, Wang J, Zhou J, Zhang Y, Li B, Li Y, Feng X, Li L, Dong Z, Wei W, Wang G. Effectiveness of one-time endoscopic screening programme in prevention of upper gastrointestinal cancer in China: a multicentre population-based cohort study. Gut 2021;70:251-60. [PMID: 32241902 DOI: 10.1136/gutjnl-2019-320200] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 15.0] [Reference Citation Analysis]
18 Fan X, Tao J, Cai Z, Fredimoses M, Wu J, Jiang Z, Zhang K, Li S. Eupafolin Suppresses Esophagus Cancer Growth by Targeting T-LAK Cell-Originated Protein Kinase. Front Pharmacol 2019;10:1248. [PMID: 31708778 DOI: 10.3389/fphar.2019.01248] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
19 Yang F, Ma D, Li Z. Screening for esophageal squamous cell carcinoma: insight from experience with Barrett's esophagus. Gastrointest Endosc 2019;89:443-444.e1. [PMID: 30665537 DOI: 10.1016/j.gie.2018.09.019] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Perbtani Y, Qumseya BJ. A prediction model for detection of esophageal squamous cell cancer: A new beginning or more of the same? Gastrointest Endosc 2020;91:1261-3. [PMID: 32439097 DOI: 10.1016/j.gie.2020.02.039] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
21 Liu M, Liu Z, Liu F, Guo C, Xu R, Li F, Liu A, Yang H, Zhang S, Shen L, Duan L, Wu Q, Cao C, Pan Y, Liu Y, Li J, Cai H, He Z, Ke Y. Absence of Iodine Staining Associates With Progression of Esophageal Lesions in a Prospective Endoscopic Surveillance Study in China. Clin Gastroenterol Hepatol. 2019;. [PMID: 31518715 DOI: 10.1016/j.cgh.2019.08.058] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
22 Su R, Cai L, Xiong P, Liu Z, Chen S, Liu X, Lin R, Lei Z, Tian D, Su M. TLR3 Expression is a Potential Prognosis Biomarker and Shapes the Immune-Active Tumor Microenvironment in Esophageal Squamous Cell Carcinoma. JIR 2022;Volume 15:1437-56. [DOI: 10.2147/jir.s348786] [Reference Citation Analysis]
23 Liu Y, Lin D, Li L, Chen Y, Wen J, Lin Y, He X. Using machine-learning algorithms to identify patients at high risk of upper gastrointestinal lesions for endoscopy. J Gastroenterol Hepatol 2021. [PMID: 33929063 DOI: 10.1111/jgh.15530] [Reference Citation Analysis]
24 Gao Y, Xin L, Feng YD, Yao B, Lin H, Sun C, An W, Li ZS, Shi RH, Wang LW. Feasibility and Accuracy of Artificial Intelligence-Assisted Sponge Cytology for Community-Based Esophageal Squamous Cell Carcinoma Screening in China. Am J Gastroenterol 2021;116:2207-15. [PMID: 34546186 DOI: 10.14309/ajg.0000000000001499] [Reference Citation Analysis]
25 Yao B, Feng Y, Zhao K, Liang Y, Huang P, Zang J, Song J, Li M, Wang X, Shu H, Shi R. Artificial intelligence assisted cytological detection for early esophageal squamous epithelial lesions by using low-grade squamous intraepithelial lesion as diagnostic threshold. Cancer Med 2022. [PMID: 35766144 DOI: 10.1002/cam4.4984] [Reference Citation Analysis]
26 Zhu J, Ma S, Chen R, Xie S, Liu Z, Li X, Wei W. Biological correlates before esophageal cancer screening and after diagnosis. Sci Rep 2021;11:17015. [PMID: 34426626 DOI: 10.1038/s41598-021-96548-5] [Reference Citation Analysis]
27 Zhang N, Li Y, Chang X, Lei F, Ma H, Liu J, Yang J, Su M, Sun X, Zhao D, Sun Q, Wei W, Wang G, Wang J. Long-term effectiveness of one-time endoscopic screening for esophageal cancer: A community-based study in rural China. Cancer 2020;126:4511-20. [PMID: 33460056 DOI: 10.1002/cncr.33119] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
28 Liu QW, Ruan HJ, Chao WX, Li MX, Jiao YL, Ward DG, Gao SG, Qi YJ. N-linked glycoproteomic profiling in esophageal squamous cell carcinoma. World J Gastroenterol 2022; 28(29): 3869-3885 [DOI: 10.3748/wjg.v28.i29.3869] [Reference Citation Analysis]
29 Li F, Hu Y, Guo C, Lei L, Li F, Liu M, Liu Z, Pan Y, Liu F, Liu Y, Hu Z, Chen H, He Z, Ke Y. Economic Burden Conferred by Population-Level Cancer Screening on Resource-Limited Communities: Lessons From the ESECC Trial. Front Oncol 2022;12:849368. [PMID: 35387122 DOI: 10.3389/fonc.2022.849368] [Reference Citation Analysis]
30 He Z, Ke Y. Precision screening for esophageal squamous cell carcinoma in China. Chin J Cancer Res 2020;32:673-82. [PMID: 33446991 DOI: 10.21147/j.issn.1000-9604.2020.06.01] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
31 Ji L, Wang J, Yang B, Zhu J, Wang Y, Jiao J, Zhu K, Zhang M, Zhai L, Gong T, Sun C, Qin J, Wang G. Urinary protein biomarker panel predicts esophageal squamous carcinoma from control cases and other tumors. Esophagus. [DOI: 10.1007/s10388-022-00932-7] [Reference Citation Analysis]
32 Yang X, Suo C, Zhang T, Yin X, Man J, Yuan Z, Chen H, Yu J, Jin L, Chen X, Lu M, Ye W. A nomogram for screening esophageal squamous cell carcinoma based on environmental risk factors in a high-incidence area of China: a population-based case-control study. BMC Cancer 2021;21:343. [PMID: 33789604 DOI: 10.1186/s12885-021-08053-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
33 Tian H, Yang W, Hu Y, Liu Z, Chen L, Lei L, Zhang F, Cai F, Xu H, Liu M, Guo C, Chen Y, Xiao P, Chen J, Ji P, Fang Z, Liu F, Liu Y, Pan Y, Dos-Santos-Silva I, He Z, Ke Y. Estimating cancer incidence based on claims data from medical insurance systems in two areas lacking cancer registries in China. EClinicalMedicine 2020;20:100312. [PMID: 32215367 DOI: 10.1016/j.eclinm.2020.100312] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
34 Li S, Chen H, Man J, Zhang T, Yin X, He Q, Yang X, Lu M. Changing trends in the disease burden of esophageal cancer in China from 1990 to 2017 and its predicted level in 25 years. Cancer Med 2021;10:1889-99. [PMID: 33586344 DOI: 10.1002/cam4.3775] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
35 Han J, Wang L, Zhang H, Ma S, Li Y, Wang Z, Zhu G, Zhao D, Wang J, Xue F. Development and Validation of an Esophageal Squamous Cell Carcinoma Risk Prediction Model for Rural Chinese: Multicenter Cohort Study. Front Oncol 2021;11:729471. [PMID: 34527592 DOI: 10.3389/fonc.2021.729471] [Reference Citation Analysis]
36 Liu M, Zhou R, Guo C, Xu R, Liu A, Yang H, Li F, Duan L, Shen L, Wu Q, Liu Z, Liu F, Liu Y, Pan Y, Cai H, Weiss NS, He Z, Ke Y. Size of Lugol-unstained lesions as a predictor for risk of progression in premalignant lesions of the esophagus. Gastrointest Endosc 2021;93:1065-1073.e3. [PMID: 32950597 DOI: 10.1016/j.gie.2020.09.020] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
37 Li B, Cai SL, Tan WM, Li JC, Yalikong A, Feng XS, Yu HH, Lu PX, Feng Z, Yao LQ, Zhou PH, Yan B, Zhong YS. Comparative study on artificial intelligence systems for detecting early esophageal squamous cell carcinoma between narrow-band and white-light imaging. World J Gastroenterol 2021; 27(3): 281-293 [PMID: 33519142 DOI: 10.3748/wjg.v27.i3.281] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 6] [Article Influence: 8.0] [Reference Citation Analysis]
38 Chen R, Ma S, Guan C, Song G, Ma Q, Xie S, Wang M, Shao D, Li X, Wei W. The National Cohort of Esophageal Cancer-Prospective Cohort Study of Esophageal Cancer and Precancerous Lesions based on High-Risk Population in China (NCEC-HRP): study protocol. BMJ Open 2019;9:e027360. [PMID: 30948615 DOI: 10.1136/bmjopen-2018-027360] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
39 Wang H, Liu Z, Guo C, Liu M, He Y, Tian H, Pan Y, Liu F, Liu Y, Hu Z, Chen H, He Z, Ke Y. Health-seeking behavior and barriers to treatment of patients with upper gastrointestinal cancer detected by screening in rural China: real-world evidence from the ESECC trial. Lancet Reg Health West Pac 2021;12:100181. [PMID: 34527972 DOI: 10.1016/j.lanwpc.2021.100181] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
40 Wang H, Cao C, Guo C, He Y, Li F, Xu R, Liu M, Liu Z, Pan Y, Liu F, Liu Y, Li J, Cai H, He Z, Ke Y. An evaluation of EQ-5D-3L health utility scores using five country-specific tariffs in a rural population aged 45-69 years in Hua county, Henan province, China. Health Qual Life Outcomes 2020;18:228. [PMID: 32660494 DOI: 10.1186/s12955-020-01476-z] [Reference Citation Analysis]
41 Wang K, Zhang L, He ZH, Liu ZJ, Zhang L, Hu N, Jin Z, Ke Y, Duan LP. A population-based survey of gastroesophageal reflux disease in a region with high prevalence of esophageal cancer in China. Chin Med J (Engl) 2019;132:1516-23. [PMID: 31045906 DOI: 10.1097/CM9.0000000000000275] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
42 Tian H, Hu Y, Li Q, Lei L, Liu Z, Liu M, Guo C, Liu F, Liu Y, Pan Y, Dos-Santos-Silva I, He Z, Ke Y. Estimating cancer survival and prevalence with the Medical-Insurance-System-based Cancer Surveillance System (MIS-CASS): An empirical study in China. EClinicalMedicine 2021;33:100756. [PMID: 33718848 DOI: 10.1016/j.eclinm.2021.100756] [Reference Citation Analysis]
43 Yu Z, Zuo T, Yu H, Zhao Y, Zhang Y, Liu J, Dong S, Wu Y, Liu Y. Outcomes of upper gastrointestinal cancer screening in high-risk individuals: a population-based prospective study in Northeast China. BMJ Open 2022;12:e046134. [PMID: 35168959 DOI: 10.1136/bmjopen-2020-046134] [Reference Citation Analysis]
44 Hu N, Wang K, Zhang L, Liu ZJ, Jin Z, Cui RL, Zhang HJ, He ZH, Ke Y, Duan LP. Epidemiological and clinical features of functional dyspepsia in a region with a high incidence of esophageal cancer in China. Chin Med J (Engl) 2021;134:1422-30. [PMID: 34091519 DOI: 10.1097/CM9.0000000000001584] [Reference Citation Analysis]
45 Wang Z, Zhang Q, Wu B. Development of an Empirically Calibrated Model of Esophageal Squamous Cell Carcinoma in High-Risk Regions. Biomed Res Int 2019;2019:2741598. [PMID: 31240208 DOI: 10.1155/2019/2741598] [Reference Citation Analysis]
46 Yang Z, Wong IO, Deng W, Chen R, Zhou J, Wei W. Lead-time bias in esophageal cancer screening in high-risk areas in China. Chin J Cancer Res 2020;32:467-75. [PMID: 32963459 DOI: 10.21147/j.issn.1000-9604.2020.04.04] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
47 Li F, Li X, Guo C, Xu R, Li F, Pan Y, Liu M, Liu Z, Shi C, Wang H, Wang M, Tian H, Liu F, Liu Y, Li J, Cai H, Yang L, He Z, Ke Y. Estimation of Cost for Endoscopic Screening for Esophageal Cancer in a High-Risk Population in Rural China: Results from a Population-Level Randomized Controlled Trial. Pharmacoeconomics 2019;37:819-27. [PMID: 30809788 DOI: 10.1007/s40273-019-00766-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
48 Codipilly DC, Rubenstein JH, Leggett CL. Whether to screen, or who to screen, that is the question. Gastrointest Endosc 2021:S0016-5107(21)01761-2. [PMID: 34924182 DOI: 10.1016/j.gie.2021.10.024] [Reference Citation Analysis]
49 Cao M, Li H, Sun D, He S, Yu Y, Li J, Chen H, Shi J, Ren J, Li N, Chen W. Cancer screening in China: The current status, challenges, and suggestions. Cancer Lett 2021;506:120-7. [PMID: 33684533 DOI: 10.1016/j.canlet.2021.02.017] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
50 Liu M, He Z, Guo C, Xu R, Li F, Ning T, Pan Y, Li Y, Ding H, Zheng L, Zhou Y, Tian X, Yang W, Wang X, Lu F, Zhang Y, Zhao Y, Guo F, Chen K, Gao L, Sun M, Liu Y, Liu F, Hang D, Shen N, Li J, Xu Z, Wang Q, Zhang C, Abliz A, Deng Q, Li X, Liu Z, Zhang C, Yuan W, Wang H, Weiss NS, Cai H, Ke Y. Effectiveness of Intensive Endoscopic Screening for Esophageal Cancer in China: A Community-Based Study. Am J Epidemiol 2019;188:776-84. [PMID: 30608546 DOI: 10.1093/aje/kwy291] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 5.7] [Reference Citation Analysis]
51 Zhao Q, Miao C, Lu Q, Wu W, He Y, Wu S, Liu H, Lian C. Clinical Significance of Monitoring Circulating Free DNA and Plasma Heat Shock Protein 90alpha in Patients with Esophageal Squamous Cell Carcinoma. Cancer Manag Res 2021;13:2223-34. [PMID: 33707971 DOI: 10.2147/CMAR.S295927] [Reference Citation Analysis]
52 Zheng Y, Li Y, Lian J, Yang H, Li F, Zhao S, Qi Y, Zhang Y, Huang L. TNF-α-induced Tim-3 expression marks the dysfunction of infiltrating natural killer cells in human esophageal cancer. J Transl Med 2019;17:165. [PMID: 31109341 DOI: 10.1186/s12967-019-1917-0] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 9.0] [Reference Citation Analysis]